Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cashflow Statement

NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹346 Cr₹401 Cr₹216 Cr₹82 Cr₹105 Cr
Adjustment ₹-12 Cr₹62 Cr₹78 Cr₹66 Cr₹40 Cr
Changes In working Capital ₹58 Cr₹-91 Cr₹-13 Cr₹-68 Cr₹49 Cr
Cash Flow after changes in Working Capital ₹392 Cr₹373 Cr₹281 Cr₹81 Cr₹195 Cr
Cash Flow from Operating Activities ₹317 Cr₹261 Cr₹237 Cr₹60 Cr₹189 Cr
Cash Flow from Investing Activities ₹-298 Cr₹-150 Cr₹-61 Cr₹-96 Cr₹-84 Cr
Cash Flow from Financing Activities ₹25 Cr₹-69 Cr₹-136 Cr₹38 Cr₹-114 Cr
Net Cash Inflow / Outflow ₹44 Cr₹42 Cr₹40 Cr₹2.59 Cr₹-8.72 Cr
Opening Cash & Cash Equivalents ₹88 Cr₹45 Cr₹5.09 Cr₹2.44 Cr₹11 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹0.17 Cr₹-0.05 Cr₹0.41 Cr₹0.06 Cr₹-0.05 Cr
Closing Cash & Cash Equivalent ₹132 Cr₹88 Cr₹45 Cr₹5.09 Cr₹2.44 Cr

Compare Cashflow Statement of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,896.4 Cr -2.8% -8.9% -4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,439.0 Cr 5.7% -3.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹162,903.0 Cr 1.6% -7.6% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,466.0 Cr -0.5% 0.9% 23.6% Stock Analytics
CIPLA ₹107,653.0 Cr 0.5% -12.9% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹103,924.0 Cr 5.3% -0.9% 1.9% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.8%

-8.9%

-4.3%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses